Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment-Reference-Cited by-同舟云学术

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment

Published:2020-07 Issue:1 Volume:83 Page:285-287
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Gisondi Paolo,Zaza Gianluigi,Del Giglio Micol,Rossi Mattia,Iacono Valentina,Girolomoni Giampiero

Publisher

Elsevier BV

Subject

Dermatology

Reference2 articles.

1. Should patients stop their biologic treatment during the COVID-19 pandemic;Bashyam;J Dermatolog Treat,2020

2. Should biologics for psoriasis be interrupted in the era of COVID-19?;Lebwohl;J Am Acad Dermatol,2020

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30

2. The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness;Current Dermatology Reports;2023-04-03

3. Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?;International Journal of Molecular Sciences;2022-10-14

4. Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis;Expert Opinion on Biological Therapy;2022-08-08

5. Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry;JEADV Clinical Practice;2022-06-24